RenaissThera Overview

  • Year Founded
  • 2023

Year Founded

  • Status
  • Private

  • Employees
  • 6

Employees

  • Latest Deal Type
  • Seed

  • Investors
  • 2

RenaissThera General Information

Description

Developer of a small-molecule therapeutics platform designed to develop affordable therapies for cardio-metabolic diseases through AI-enabled drug discovery. The company offers small-molecule drug development, target identification, molecule discovery, generative AI platforms, obesity therapeutics, and diabetes therapeutics, enabling patients with cardio-metabolic conditions to access affordable therapeutic options.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Number 390, 1st Floor, 7th Main
  • 9th Cross Road, 2nd Block Jayanagar
  • Bengaluru, Karnataka 560111
  • India
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Corporate Office
  • Number 390, 1st Floor, 7th Main
  • 9th Cross Road, 2nd Block Jayanagar
  • Bengaluru, Karnataka 560111
  • India

RenaissThera Timeline

202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

RenaissThera Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Seed Round 23-Jun-2026 Completed Pre-Clinical Trials
2. Accelerator/Incubator 13-Nov-2025 Completed Pre-Clinical Trials
1. Angel (individual) 09-Dec-2024 $497K $497K Completed Pre-Clinical Trials
To view RenaissThera’s complete valuation and funding history, request access »

RenaissThera Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordinary
To view RenaissThera’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

RenaissThera Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

RenaissThera Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
Arali Ventures Venture Capital Minority
Centre for Cellular And Molecular Platforms Accelerator/Incubator
To view RenaissThera’s complete investors history, request access »

RenaissThera FAQs

  • When was RenaissThera founded?

    RenaissThera was founded in 2023.

  • Where is RenaissThera headquartered?

    RenaissThera is headquartered in Bengaluru, India.

  • What is the size of RenaissThera?

    RenaissThera has 6 total employees.

  • What industry is RenaissThera in?

    RenaissThera’s primary industry is Drug Discovery.

  • Is RenaissThera a private or public company?

    RenaissThera is a Private company.

  • What is RenaissThera’s current revenue?

    The current revenue for RenaissThera is .

  • How much funding has RenaissThera raised over time?

    RenaissThera has raised $497K.

  • Who are RenaissThera’s investors?

    Arali Ventures and Centre for Cellular And Molecular Platforms have invested in RenaissThera.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process